Crystal forms of tetra-hydro-n, n-dimethyl-2, 2-diphenyl-3-furanmethanamine hydrochloride, processes for making such forms, and their pharmaceutical compositions
作者： Linda Sharon Daintree , Daniel Mark Ledger , Peter York , Lucy Anne Leonard
DOI:
关键词:
摘要: Polymorphic forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3- furanmethanamine hydrochloride (ANAVEX2-73) and a metabolite tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine are disclosed characterized. Compositions method for treatment Alzheimer's disease that includes the polymorphic tetrahydro-N,N-dimethyl-2,2- diphenyl-3-furanmethanamine (ANAVEX2-73).
lens.org 参考文章(9)
Stephen Byrn, Ralph Pfeiffer, Michael Ganey, Charles Hoiberg, Guirag Poochikian, Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations Pharmaceutical Research. ,vol. 12, pp. 945- 954 ,(1995) , 10.1023/A:1016241927429
Andréanne Bouchard, Nataša Jovanović, Gerard W. Hofland, Daan J.A. Crommelin, Wim Jiskoot, Geert-Jan Witkamp, Ways of manipulating the polymorphism of glycine during supercritical fluid crystallisation Journal of Supercritical Fluids. ,vol. 44, pp. 422- 432 ,(2008) , 10.1016/J.SUPFLU.2007.09.016
Valentine Lahmy, Johann Meunier, Susanna Malmström, Gaelle Naert, Laurent Givalois, Seung Hyun Kim, Vanessa Villard, Alexandre Vamvakides, Tangui Maurice, Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer's Disease Neuropsychopharmacology. ,vol. 38, pp. 1706- 1723 ,(2013) , 10.1038/NPP.2013.70
Vanessa Villard, Julie Espallergues, Emeline Keller, Alexandre Vamvakides, Tangui Maurice, Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative. Journal of Psychopharmacology. ,vol. 25, pp. 1101- 1117 ,(2011) , 10.1177/0269881110379286
Alexandre Wamvakides, Martine Schmitt, Vassilios Moutsos, Synthesis of (+) and (-) 1 -(5,5-diphenyltetrahydrofuran-3- yl)-n,n-dimethylmethanamine, (+) and (-) 1-(2,2-diphenyltetrahydrofuran-3-yl)-n,n- dimethylmethanamine and (+) and (-) 1-(2,2- dffhenyltetrahydrofuran-3-yl)-n-metihylmethanamine ,(2012)
George Foscolos, George Fytas, Alexandre Vamvakides, Nikolais Pouli, Nikolaos Colocouris, Zoi Papadopoulou-Daïfoti, Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-feranemethanamine, its enantiomers, and their pharmaceutically acceptable acid addition salts ,(1997)
Pouli N, Foscolos Gb, Fytas G, Vamvakides A, Marakos P, Kolocouris N, Synthesis and pharmacological study of some new beta-(dialkylaminomethyl)- gamma-butyrolactones and their tetrahydrofuran analogues. Farmaco. ,vol. 51, pp. 19- 26 ,(1996)